Corient Private Wealth LLC - NYMOX PHARMACEUTICAL CORP ownership

NYMOX PHARMACEUTICAL CORP's ticker is NYMX and the CUSIP is P73398102. A total of 35 filers reported holding NYMOX PHARMACEUTICAL CORP in Q1 2023. The put-call ratio across all filers is - and the average weighting 0.0%.

Quarter-by-quarter ownership
Corient Private Wealth LLC ownership history of NYMOX PHARMACEUTICAL CORP
ValueSharesWeighting
Q2 2023$4,750
-44.1%
25,0000.0%0.00%
Q1 2023$8,500
+14.5%
25,0000.0%0.00%
Q4 2022$7,42525,0000.00%
Other shareholders
NYMOX PHARMACEUTICAL CORP shareholders Q1 2023
NameSharesValueWeighting ↓
First Citizens Financial Corp 35,100$82,0000.11%
Patriot Financial Group Insurance Agency, LLC 71,060$166,0000.08%
Willow Creek Wealth Management Inc. 24,224$57,0000.03%
WEBSTER BANK, N. A. 60,000$140,0000.02%
HighPoint Advisor Group LLC 34,000$98,0000.02%
Brown Advisory Securities, LLC 28,000$60,0000.02%
WMS Partners, LLC 18,000$42,0000.01%
WEDBUSH SECURITIES INC 33,900$79,0000.01%
ExodusPoint Capital Management, LP 56,618$132,0000.01%
Qube Research & Technologies Ltd 66,800$156,0000.01%
View complete list of NYMOX PHARMACEUTICAL CORP shareholders